Belly Fat Linked to Heart Failure Risk Even in People with Normal Weight

Why It Matters

Identifying central adiposity as a key risk factor reshapes screening and prevention strategies, potentially reducing heart‑failure incidence before symptoms appear.

Key Takeaways

• Visceral fat outperforms BMI in heart failure prediction
• Inflammation mediates one‑third of abdominal fat risk
• Waist circumference predicts risk in normal‑BMI individuals
• Study based on 1,998 African‑American participants
• Findings support adding waist metrics to preventive care

Pulse Analysis

The American Heart Association’s 2026 EPI|Lifestyle Scientific Sessions highlighted a pivotal shift in how cardiovascular risk is assessed. While body‑mass index has long been the default metric for obesity, the new Jackson Heart Study analysis demonstrates that waist circumference and waist‑to‑height ratio capture the harmful effects of visceral fat far more accurately. In a sample of nearly 2,000 African‑American adults, 112 participants developed heart failure over a median 6.9‑year follow‑up, and the statistical models showed that central adiposity, not BMI, drove the association. This evidence reinforces a growing consensus that where fat is stored matters more than how much.

The biological bridge between belly fat and heart failure appears to be systemic inflammation. Participants with elevated high‑sensitivity C‑reactive protein—a marker of low‑grade inflammation—experienced a 25‑30 % higher risk, indicating that inflammatory pathways account for roughly a quarter to a third of the visceral‑fat risk link. Inflammation can impair endothelial function, promote myocardial fibrosis, and accelerate ventricular remodeling, all of which predispose to heart failure. Recognizing inflammation as a modifiable mediator opens therapeutic avenues, from lifestyle interventions that reduce visceral fat to anti‑inflammatory agents under investigation.

From a clinical perspective, the findings argue for routine waist‑measurement alongside BMI in primary‑care visits, especially for patients with normal weight but elevated waist size. Incorporating waist‑to‑height ratio into existing risk calculators, such as the PREVENT‑HF equation, could sharpen early detection and enable targeted prevention programs—dietary counseling, physical activity, and weight‑loss strategies focused on abdominal fat. Future research should dissect how different heart‑failure phenotypes respond to reductions in visceral adiposity and inflammation, guiding precision medicine approaches. As public‑health policies evolve, emphasizing central obesity may improve cardiovascular outcomes across diverse populations.